- Home
- DTCK vs BIAF Comparison
DTCK vs BIAF Comparison
Compare DTCK & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTCK
- BIAF
- Stock Information
- Founded
- DTCK 1999
- BIAF 2014
- Country
- DTCK Singapore
- BIAF United States
- Employees
- DTCK N/A
- BIAF N/A
- Industry
- DTCK Farming/Seeds/Milling
- BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- DTCK Industrials
- BIAF Health Care
- Exchange
- DTCK Nasdaq
- BIAF Nasdaq
- Market Cap
- DTCK 26.5M
- BIAF 21.4M
- IPO Year
- DTCK 2023
- BIAF 2022
- Fundamental
- Price
- DTCK $0.97
- BIAF $1.24
- Analyst Decision
- DTCK
- BIAF Strong Buy
- Analyst Count
- DTCK 0
- BIAF 1
- Target Price
- DTCK N/A
- BIAF $6.00
- AVG Volume (30 Days)
- DTCK 35.7K
- BIAF 102.5K
- Earning Date
- DTCK 11-13-2024
- BIAF 11-14-2024
- Dividend Yield
- DTCK N/A
- BIAF N/A
- EPS Growth
- DTCK N/A
- BIAF N/A
- EPS
- DTCK 0.02
- BIAF N/A
- Revenue
- DTCK $159,836,000.00
- BIAF $9,367,785.00
- Revenue This Year
- DTCK N/A
- BIAF $302.41
- Revenue Next Year
- DTCK N/A
- BIAF $15.00
- P/E Ratio
- DTCK $48.58
- BIAF N/A
- Revenue Growth
- DTCK N/A
- BIAF 2813.87
- 52 Week Low
- DTCK $0.76
- BIAF $1.20
- 52 Week High
- DTCK $1.75
- BIAF $3.62
- Technical
- Relative Strength Index (RSI)
- DTCK 35.81
- BIAF 36.67
- Support Level
- DTCK $0.87
- BIAF $1.21
- Resistance Level
- DTCK $1.05
- BIAF $1.37
- Average True Range (ATR)
- DTCK 0.07
- BIAF 0.08
- MACD
- DTCK -0.02
- BIAF 0.01
- Stochastic Oscillator
- DTCK 28.88
- BIAF 17.50
About DTCK Davis Commodities Limited
Davis Commodities Ltd is an agricultural commodity trading company based in Singapore which specializes in trading of three main categories of agricultural commodities namely sugar, rice, and oil and fat products. It distributes agricultural commodities to various markets, including Asia, Africa and the Middle East. The company also provides customers of commodity offerings with complementary, ancillary services such as warehouse handling and storage and logistics services. The Company operates across four main segments: the sale of sugar, rice, oil and fat products, and others. Among these, the sale of sugar stands out as the primary revenue generator, contributing significantly to the company's overall income.
About BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.